# Drug Eluting Stents Versus Bare Metal Stents for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis

> **NCT03201432** · PHASE2,PHASE3 · COMPLETED · sponsor: **Xiongjing Jiang** · enrollment: 160 (actual)

## Conditions studied

- Ischemic Stroke
- Vertebral Artery Stenosis

## Interventions

- **DEVICE:** Drug eluting stent (DES)
- **DEVICE:** Bare metal stent (BES)

## Key facts

- **NCT ID:** NCT03201432
- **Lead sponsor:** Xiongjing Jiang
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2017-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03201432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03201432, "Drug Eluting Stents Versus Bare Metal Stents for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03201432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*